Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-26

Clinical Trial Update: Topical Bimatoprost in the Treatment of Migraine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update involving topical bimatoprost for migraine treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

Sponsor: Manistee Partners | Conditions: Migraine Disorders, Headache Disorders | Phase 2 | Status: UNKNOWN